Salmeterol Effect on Exercise Performance
Launched by UNIVERSITY OF COPENHAGEN · Oct 22, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Salmeterol Effect on Exercise Performance," is looking to understand how a medication called salmeterol affects muscle response during exercise in young, healthy individuals. The study aims to see how this medication can help improve muscle performance and function when people engage in physical activities.
To participate in this trial, you'll need to be between 18 and 40 years old and physically active, meaning you work out or exercise for more than five hours a week. You should also have a high level of fitness, indicated by your maximum oxygen uptake. However, if you are a smoker, currently pregnant, or have certain health conditions or medications that might interfere with the study, you won’t be eligible. If you join, you can expect to undergo some tests related to your exercise performance with the medication, all while being supported by the study team. This is a great opportunity to contribute to research that could help improve exercise performance for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Inclusion Criteria:
- • Age 18-40
- • Physically active \>5 hours a week
- • Maximum oxygen uptake classified as high or very high
- Exclusion Criteria:
- • Active smoker currently or within the past 5 years
- • Regular intake of medication deemed by the responsible study physician to affect the test parameters (hormonal contraception is accepted for women)
- • Chronic or acute illness deemed by the responsible study physician to affect the test parameters
- • Deviation from the study protocol
- • Lean mass index \>21 kg/m²
- • Pregnancy
- • Smoker
- • Blood donation during the past 3 months
About University Of Copenhagen
The University of Copenhagen, a leading research institution in Denmark, is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, pharmacology, and biotechnology, to design and conduct rigorous clinical studies. Committed to ethical standards and scientific integrity, the University of Copenhagen aims to contribute significantly to the global medical community by facilitating groundbreaking research that addresses pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported